# Vitade

*/Startups/Vitade*

## Startup Overview

This platform verifies patient medication ingestion through remote video analysis. Using standard smartphone or tablet cameras, the system observes dosing events to confirm the correct pill, dosage, and actual swallowing action. Clinical trials and remote care providers receive immutable video logs of exact adherence events.

Administrators and remote healthcare providers struggle to track true medication adherence. Current methods rely on manual pill counts that require costly in-person visits or self-reported e-diaries that introduce human error and bias. Missing or falsified ingestion data compromises trial integrity and patient health outcomes.

Unlike self-reported e-diaries, manual pill counts, or active-prompt applications like AiCure, this ingestion tracking is completely passive for the patient. Users simply set their device in view while taking their medication, requiring no additional taps, logging, or interaction. The computer vision engine delivers clinically validated audit accuracy, removing reporting friction while providing absolute certainty of adherence.

## Startup Founding Hypothesis

**Approach**: that verifies patient medication ingestion via remote video analysis
**Competitors**:
- [AiCure](/Competitors/AiCure)
- [Manual Pill Counts](/Competitors/Manual_Pill_Counts)
- [Self-Reported E-Diaries](/Competitors/Self-Reported_E-Diaries)
**Differentiator2x2**: clinically validated in audit accuracy and completely passive for the patient

## Startup Solution Coordinate

**Solution**: [Ingestion Verification Engine](/Software/Ingestion_Verification_Engine)

## Startup Position2x2

```mermaid
quadrantChart
    title Medication Adherence Verification
    x-axis Low Audit Accuracy --> High Audit Accuracy
    y-axis High Patient Effort --> Completely Passive
    quadrant-1 Passive Validation
    quadrant-2 Unverified Convenience
    quadrant-3 High Burden & Low Trust
    quadrant-4 Validated but Burdensome
    Self-Reported E-Diaries: [0.2, 0.3]
    Manual Pill Counts: [0.5, 0.15]
    AiCure: [0.8, 0.2]
    Vitade: [0.9, 0.9]
```

## Startup Offer

**Proof**:
- Targeting >99% ingestion verification accuracy against manual observer baselines.
- Aiming to reduce clinical trial coordinator follow-up hours by 75% compared to self-reported e-diaries.
- Designed to push trial protocol adherence above 90% without requiring physical pill counts.
**Tiers**:
- Name: Phase I-II Trials · Price: ~$40–$80 per patient/mo · Inclusions: Automated remote video analysis for up to 250 patients, daily ingestion verification logs, and standard audit reporting designed for early-stage clinical trials.
- Name: Phase III & Commercial · Price: ~$75–$150 per patient/mo · Inclusions: Unlimited patient volume, human-in-the-loop exception routing for ambiguous frames, and intended direct integration with major Electronic Data Capture (EDC) systems.
**Guarantee**: If the computer vision model fails to match human-reviewer accuracy benchmarks for clear ingestion events during your validation pilot, we refund the software usage fees for that cohort.
**Business Function**: ProvideService
**Objection Handlers**:
- Patients will find video recording invasive or difficult. -> The interface is designed to be completely passive; the patient simply faces their smartphone camera while taking their dose, with no manual data entry required.
- Patients can trick the camera by 'cheeking' the pill. -> The analysis maps physiological swallowing mechanics and throat movement, not just pill-to-mouth proximity, to verify actual ingestion.
- How is patient privacy maintained with video data? -> The platform is engineered to process frames in transient memory, immediately discarding the raw video and logging only the verified event token to your HIPAA-compliant database.
- What happens in low light or bad camera angles? -> The model identifies poor capture conditions in real-time and prompts the patient to adjust before they take the medication, ensuring the event is captured cleanly.
**Pricing Architecture**: UsageMeter
**Agent Checkout Support**:
- agentic-commerce-protocol

## Startup Brand

**Voice**: Objective medical register driven by clinical precision.
**Tagline**: Clinically validated proof of patient medication ingestion.
**Icon Concept**: capsule
**Palette Intent**: institutional-cool
**Visual Identity**: Crisp clinical whites and sterile blues pair with clean sans-serif typography and soft-focus patient imagery to project medical authority.
**Archetype Reference**: the-sage

## Startup Buyer Chain

**Chain**: Vitade → Clinical Trial CROs / Pharma Sponsors → Trial Patients
**Gtm Motion**: Direct enterprise sales targeting clinical operations and innovation leads at CROs during trial protocol design, expanding from a single Phase II pilot to broader, multi-site Phase III trial adoption as the passive tracking proves its data integrity.
**Agent Channel**: Designed to be listed in standardized digital biomarker and eCOA (electronic Clinical Outcome Assessment) registries, allowing AI-driven clinical protocol design agents to programmatically select Vitade as a verified adherence tracking module.
**Primary Channel**: Targeted enterprise outreach triggered by new Phase II/III trial announcements on ClinicalTrials.gov, alongside intended partnership listings in eClinical marketplaces like the Medidata Rave or Veeva Vault partner networks.

## Startup Customer Journey

```mermaid
flowchart LR; A[ClinicalTrials.gov Alert] --> B[Clinical Operations Lead]; B --> C[Phase II Pilot]; C --> D[Patient Smartphone Interface]; D --> E[Swallow Verification Log]; E --> F[Electronic Data Capture System]; F --> G[Phase III Multi-site Trial]; G --> H[eCOA Biomarker Registry];
```

## Startup Proof Points

_Illustrative — target and order-of-magnitude estimate figures, not an achieved track record (this Thing is concept-stage)._

**Pilot Goals**:
- 30-day pilot with a 50-patient cohort designed to prove that the computer vision model matches or exceeds human-reviewer accuracy benchmarks for clear ingestion events.
- 60-day shadow deployment alongside an existing Phase II trial to validate that real-time poor-lighting prompts reduce unusable capture events to near zero prior to full Electronic Data Capture integration.
**Target Metrics**:
- Target: >99% ingestion verification accuracy against manual human observer baselines.
- Target: 75% reduction in clinical trial coordinator follow-up hours compared to traditional self-reported e-diary methods.
- Aim: >90% trial protocol medication adherence rate achieved without physical pill counts.
- Target: 0 raw patient video files stored post-verification, ensuring total HIPAA compliance through transient memory processing.
**Target Case Studies**:
- Mid-sized Contract Research Organization (CRO) Clinical Trial Manager aims to replace physical pill counts and self-reported e-diaries with passive video verification, targeting over 90% protocol adherence without requiring additional clinical staff hours.
- Enterprise Pharmaceutical Sponsor (Phase III) seeks to eliminate medication cheeking in complex drug trials, utilizing physiological swallowing mechanics mapping to guarantee ingestion data integrity for FDA submissions.
- Clinical Operations Director at a rare disease biotech startup aims to fully decentralize a global trial, using automated remote video analysis to verify daily ingestion and cut required patient site visits by half.
**Testimonial Targets**:
- Clinical Trial Coordinator expressing relief that they no longer spend hours chasing patients on the phone to verify ambiguous e-diary entries, relying entirely on the daily ingestion verification logs.
- Principal Investigator stating that the physiological swallowing verification provides unprecedented confidence in the trial's medication adherence data, far exceeding standard proximity checks.
- Trial Participant confirming that the passive smartphone video capture was completely frictionless, entirely private, and easier than filling out daily manual logs.

## Startup Top Risks

**Risks**:
- Severity: existential · Description: Regulatory bodies or institutional review boards reject passive video monitoring as a valid medication adherence endpoint due to home privacy concerns · Mitigation Status: in-progress
- Severity: high · Description: The video analysis model fails to accurately detect pill ingestion in poorly lit rooms or off-angle camera setups · Mitigation Status: in-progress
- Severity: moderate · Description: Healthcare providers refuse to adopt the system because integrating continuous video data streams into existing electronic health records requires heavy custom engineering · Mitigation Status: unmitigated
- Severity: low · Description: Patients accidentally obstruct the camera line-of-sight with household objects causing temporary drops in audit accuracy · Mitigation Status: unmitigated

## Startup Competitors

- [AiCure](/Competitors/AiCure) — Direct Competitor
- [Manual Pill Counts](/Competitors/Manual_Pill_Counts) — Status Quo
- [Self-Reported E-Diaries](/Competitors/Self-Reported_E-Diaries) — Status Quo
- [Emocha Health](/Competitors/Emocha_Health) — Video Adherence
- [Ingestible Sensors](/Competitors/Ingestible_Sensors) — Hardware Alternative

## Startup Solution Stack

- [Ingestion Audit Service](/Services/Ingestion_Audit_Service) — Service-as-Software
- [Video Analysis Agent](/Agents/Video_Analysis_Agent) — Agent
- [Swallow Detection Agent](/Agents/Swallow_Detection_Agent) — Agent
- [Computer Vision SDK](/Software/Computer_Vision_SDK) — Software
- [Audit Reporting API](/Software/Audit_Reporting_API) — Software

## Startup Story Brand

**Hero**:
- **Need**: to be the trial leader who delivers unassailable efficacy data, not questionable self-reports
- **Want**: to verify patient medication adherence with audit-level precision
- **Identity**: a clinical trial manager at a mid-market biotech firm
**Plan**:
- Step: Upload protocol · Detail: Specify dose timing and patient cohorts within our dashboard to align verification with your study design.
- Step: Verify ingestion · Detail: Review automated logs where our vision model confirms medication events against physiological swallowing markers.
- Step: Export logs · Detail: Download audit-ready adherence reports directly into your Electronic Data Capture system for immediate analysis.
**Guide**:
- **Empathy**: Does your ingestion verification process still rely on manual bottle counts and patient memory?
**Problem**:
- **Villain**: manual pill counts
- **External**: Verifying protocol adherence in Phase III trials currently relies on patient self-reported e-diaries and physical bottle counts that miss 'cheeking' and delayed doses.
- **Internal**: You feel constant anxiety that your trial data is compromised by unreliable ingestion logs.
- **Philosophical**: Every clinical researcher deserves objective proof of adherence — not the guesswork of an e-diary.
**Success**: You achieve over 90% protocol adherence with objective, video-verified ingestion logs that satisfy every auditor's requirement.
**One Liner**: What if you had absolute proof every patient swallowed their dose? Vitade uses remote video analysis of swallowing mechanics to deliver clinically validated adherence data.
**Positioning**:
- **So That**: replace patient guesswork with physiological proof of ingestion
- **Unlike**: self-reported e-diaries
- **For Whom**: clinical trial managers at biotech firms
- **Category**: Automated medication adherence verification
**Call To Action**:
- **Direct**: Launch validation pilot
- **Transitional**: View ingestion accuracy report
**Failure Stakes**:
- Compromised trial data integrity
- Costly recruitment for failed cohorts
- Delayed FDA submission timelines
**Transformation**:
- **To**: free to focus on clinical endpoints, no longer auditing plastic pill bottles
- **From**: a trial manager chasing patients for unverified e-diary entries
**Controlling Idea**: Objective ingestion verification is the only way to guarantee clinical trial data integrity.

## Startup Token Hero

**Genre**: founding-hypothesis
**Rendered**: What if you had absolute proof every patient swallowed their dose? Vitade uses remote video analysis of swallowing mechanics to deliver clinically validated adherence data.
**Mechanism**: spine-derived-v1
**Template Id**: spine-founding-hypothesis
**Vocab Fingerprint**: 3db3d685582691d4

## Startup Token Positioning

**Genre**: moore-positioning
**Rendered**: Automated medication adherence verification for clinical trial managers at biotech firms. Unlike self-reported e-diaries — replace patient guesswork with physiological proof of ingestion.
**Mechanism**: spine-derived-v1
**Template Id**: spine-moore-positioning
**Vocab Fingerprint**: afeb9eeb33271459

## Startup Token Pitch Deck

**Genre**: pitch-deck
**Rendered**: Problem: Verifying protocol adherence in Phase III trials currently relies on patient self-reported e-diaries and physical bottle counts that miss 'cheeking' and delayed doses.
Solution: What if you had absolute proof every patient swallowed their dose? Vitade uses remote video analysis of swallowing mechanics to deliver clinically validated adherence data.
Customer: clinical trial managers at biotech firms
Unlike: self-reported e-diaries
**Mechanism**: spine-derived-v1
**Template Id**: spine-pitch-deck
**Vocab Fingerprint**: 18dbf17bbef3ecdf

## Startup Token M E D D P I C C

**Pain**: Verifying protocol adherence in Phase III trials currently relies on patient self-reported e-diaries and physical bottle counts that miss 'cheeking' and delayed doses.
**Metrics**: Target: You achieve over 90% protocol adherence with objective, video-verified ingestion logs that satisfy every auditor's requirement.
**Rendered**: Pain: Verifying protocol adherence in Phase III trials currently relies on patient self-reported e-diaries and physical bottle counts that miss 'cheeking' and delayed doses.
Economic buyer: Clinical Trial CROs / Pharma Sponsors
Metrics: Target: You achieve over 90% protocol adherence with objective, video-verified ingestion logs that satisfy every auditor's requirement.
Competition: self-reported e-diaries
**Mechanism**: spine-derived-v1
**Competition**: self-reported e-diaries
**Economic Buyer**: Clinical Trial CROs / Pharma Sponsors
**Vocab Fingerprint**: 44ba5a325b398881

## Startup Token Cold Email

**Genre**: cold-email
**Rendered**: Subject: Automated medication adherence verification for clinical trial managers at biotech firms

clinical trial managers at biotech firms — Verifying protocol adherence in Phase III trials currently relies on patient self-reported e-diaries and physical bottle counts that miss 'cheeking' and delayed doses. What if you had absolute proof every patient swallowed their dose? Vitade uses remote video analysis of swallowing mechanics to deliver clinically validated adherence data.
**Mechanism**: spine-derived-v1
**Template Id**: spine-cold-email
**Vocab Fingerprint**: f56cf7d6e542d9f2

## Startup Token Agent Spec

**Genre**: ai-agent-spec
**Rendered**: Automated medication adherence verification. What if you had absolute proof every patient swallowed their dose? Vitade uses remote video analysis of swallowing mechanics to deliver clinically validated adherence data. Serves clinical trial managers at biotech firms.
**Mechanism**: spine-derived-v1
**Template Id**: spine-ai-agent-spec
**Vocab Fingerprint**: 9fae5aa0d90ea5b2

## Neighborhood

### Candidate solutions

- [Missed Processing SLAs](/Problems/Missed_Processing_SLAs) — candidate solution for · Problems
- [Cross-Dock Throughput Bottlenecks](/Problems/Cross-Dock_Throughput_Bottlenecks) — candidate solution for · Problems

### What it offers

- [Ingestion Verification Engine](/Software/Ingestion_Verification_Engine) — offers · Software

### Composed of

- [Ingestion Audit Service](/Services/Ingestion_Audit_Service) — composes · Services
- [Video Analysis Agent](/Agents/Video_Analysis_Agent) — composes · Agents
- [Swallow Detection Agent](/Agents/Swallow_Detection_Agent) — composes · Agents
- [Computer Vision SDK](/Software/Computer_Vision_SDK) — composes · Software
- [Audit Reporting API](/Software/Audit_Reporting_API) — composes · Software

### Embodies

- [Software](/Theses/Software) — embodies · Theses

### Competitors

- [AiCure](/Competitors/AiCure) — competes with · Competitors
- [Manual Pill Counts](/Competitors/Manual_Pill_Counts) — competes with · Competitors
- [Self-Reported E-Diaries](/Competitors/Self-Reported_E-Diaries) — competes with · Competitors
- [Emocha Health](/Competitors/Emocha_Health) — competes with · Competitors
- [Ingestible Sensors](/Competitors/Ingestible_Sensors) — competes with · Competitors

### Similar Startups

- [Adherenceside](/Startups/Adherenceside) — similar · Startups
- [Adherenceshed](/Startups/Adherenceshed) — similar · Startups
- [Priment](/Occupations/Occupational_Therapy_Assistants_and_Aides/Problems/Therapy_Plan_Abandonment/Startups/Priment) — similar · Startups
- [Rehabilitateguild](/Startups/Rehabilitateguild) — similar · Startups
- [Outpidge](/Occupations/Occupational_Therapy_Assistants_and_Aides/Problems/Therapy_Plan_Abandonment/Startups/Outpidge) — similar · Startups
- [Bodyridge](/Startups/Bodyridge) — similar · Startups
- [Acutetube](/Startups/Acutetube) — similar · Startups
- [Thrivevessel](/Startups/Thrivevessel) — similar · Startups
- [Truegrove](/Occupations/Miscellaneous_Health_Technologists_and_Technicians/Problems/Diagnostic_Equipment_Calibration_Audits/Startups/Truegrove) — similar · Startups
- [Adherenceoperators](/Startups/Adherenceoperators) — similar · Startups
- [Trialtone](/Startups/Trialtone) — similar · Startups
- [Chronicsight](/Startups/Chronicsight) — similar · Startups
- [Chronichaven](/Startups/Chronichaven) — similar · Startups
- [Medanager](/Startups/Medanager) — similar · Startups
- [Adherencyard](/Problems/Immunotherapy_Patient_Adherence/Startups/Adherencyard) — similar · Startups
- [Outpaction](/Occupations/Occupational_Therapy_Assistants_and_Aides/Problems/Therapy_Plan_Abandonment/Startups/Outpaction) — similar · Startups
- [Duoproctoring](/Startups/Duoproctoring) — similar · Startups
- [Abinlet](/Occupations/Occupational_Therapy_Assistants_and_Aides/Problems/Therapy_Plan_Abandonment/Startups/Abinlet) — similar · Startups
- [Adherenceforge](/Occupations/Occupational_Therapy_Assistants_and_Aides/Problems/Therapy_Plan_Abandonment/Startups/Adherenceforge) — similar · Startups
- [Registriestrek](/CompanyTypes/Private_Behavioral_Health_Groups/Problems/Cross-Reference_PDMP_Registries/Startups/Registriestrek) — similar · Startups